Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Iclick Interactive Asia Group

WKN: A3DWMU / Name: Iclick Interactive Asia Group / Stock / Micro Cap /

?
-1.870%

Icon plc

WKN: 932242 / Symbol: ICLR / Name: ICON / Stock / Biotechnology & Medical Research / Mid Cap /

€144.45
0.510%

ICL Group (ICL) Surpasses Q2 Earnings and Revenue Estimates
ICL Group (ICL) Surpasses Q2 Earnings and Revenue Estimates

ICL Group (ICL) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.09 per share a year ago. These figures

ICL Group Q2 Earnings Call Highlights
ICL Group Q2 Earnings Call Highlights

Key Points

ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen

ICON Public Limited Company ICLR shares have gained 33.2% in the past three months, reflecting renewed confidence in a recovery despite lingering earnings and internal-control risks.

Improving

Cell Impact AB

WKN: A3DL44 / Name: Cell Impact / Stock / Machinery, Equipment & Components / Micro Cap /

€0.003
7.140%

Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?

ICON Public Limited Company ICLR presents a mixed investment case. The stock trades below several key benchmarks, while new business awards and backlog point to healthier commercial demand.

That